Skip to content

Effect of transcutaneous nerve electrostimulation (TENS) during bodybuilding exercise in the control of pain and physical performance of healthy adults

Effect of transcutaneous nerve electrostimulation (TENS) during exercise In the control of pain and in the physical performance of healthy individuals

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5twbsm
Enrollment
Unknown
Registered
2017-07-12
Start date
2016-08-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myalgia

Interventions

A total of 44 individuals will be recruited to be divided into two study groups (22 in each group), described below: Motor intensity: the current will be applied with motor intensity for 20 minutes (P
Device
Other
E02.760.169.063.500.387.875
E02.331.800

Sponsors

Universidade Federal de Sergipe
Lead Sponsor
Universidade Federal de Sergipe
Collaborator

Eligibility

Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: The sample will consist of healthy; university students; of both sexes; aged 18 and 40; who will be recruited on São Cristóvão campus of Federal University of Sergipe; through personal contacts with them on campus facilities and dissemination by email; irregularly active; and have not performed resistance training of the muscles of the upper limbs for two months prior to the survey. The short version of the international physical activity questionnaire (IPAQ), validated in portuguese, will be used to ensure the eligibility of the sample.

Exclusion criteria

Exclusion criteria: They have any musculoskeletal, cardiovascular, neurological or systemic disorder that can be exacerbated by strenuous exercise (eg, recent injury; chronic pain; heart disease). Potential medical contraindications for the study of exercise protocol will be further evaluated using a questionnaire prepared by the author, based on the physical activity readiness questionnaire (PAR-Q, 2011). The subjects who have had some experience with TENS or any contraindication to prevent the use of electrical stimulation, such as allergy to the material of the electrodes; cardiac pacemaker use; pregnancy; epilepsy; altered skin conditions or loss of feeling in areas established for electrode placement.

Design outcomes

Primary

MeasureTime frame
Reduction of pain intensity assessed by the numerical scale of pain, at rest and during exercise, in the immediate evaluation and after 24 hours; Reduction of the pain threshold by pressure evaluated by the measurement of pressure pain threshold, immediately after exercise and after 24 hours. Central pain inhibition assessed by temporal summation, immediately after exercise, and after 24 hours; Conditional modulation of pain assessed by conditioned pain modulation test, immediately after exercise, and after 24 hours. Reduction of body temperature, evaluated by thermography, immediately after exercise and after 24 hours.

Secondary

MeasureTime frame
Reduction or control of heart rate, measured by pulse oximetry, immediately after exercise; Reduction or control of blood pressure, evaluated by sphygmomanometer, after exercise; Reduction or control of respiratory rate, assessed by observation of respiratory incursions per minute immediately after exercise; Reduction or control of peripheral oxygen saturation, measured by pulse oximetry, immediately after exercise; Improvement of the functionality, by means of the evaluation of the disabilities of the arm, shoulder and hand questionnaire, after 24h; Reduction of fatigue, at rest and during exercise, measured by the BORG questionnaire, immediately after exercise and after 24 hours; Increased physical tolerance, measured by the time of isometric contraction, immediately after exercise and after 24 hours;

Countries

Brazil

Contacts

Public ContactMayara Menezes

Universidade Federal de Sergipe

mayara_amenezes@hotmail.com+557991658549

Outcome results

None listed

Source: REBEC (via WHO ICTRP)